UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
Viruses hijack the molecular machinery in human cells to survive and replicate, often damaging those host cells in the process. Researchers at the University of California San Diego School of Medicine discovered that, for cytomegalovirus (CMV), this process relies on a human protein called CPEB1. The study provides a potential new target for the development of CMV therapies.
Professor of Cellular and Molecular Medicine Pradipta Ghosh, second guest in the series, will address “The Herculean Task of Killing Cancer Cells: Spare the Heads of Hydra; Strike the Heart,” at 4 p.m. on Tuesday, October 18, in the Roth Auditorium at the Sanford Consortium for Regenerative Medicine.
Biocom has announced the winners of its inaugural Life Science Catalyst Awards, presented in conjunction with the San Diego Venture Group, and UC San Diego-related innovators are prominent among the awardees.
The University of California San Diego has been ranked the seventh best public university across the globe by Times Higher Education World University Rankings. In its 2016–17 report, the London-based publication ranked UC San Diego 22nd in the United States and 41st internationally.
One of the hundreds of companies hatched by the University of California San Diego has a prominent presence in a national showcase of high-potential startups in the nation’s capital. Curtana Pharmaceuticals plays a big role in the high-visibility Washington, D.C. celebration as a major presenter.
“Inside Innovation,” a new series of free, public presentations, will feature the latest innovation technologies by UC San Diego, with opportunities for participants to get an inside look at what’s happening in our labs, explore commercialization opportunities, and inquire about licensing.
Forbes, May 29
San Diego Union Tribune, May 28
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
